↓ Skip to main content

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer

Overview of attention for article published in BMC Cancer, December 2022
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer
Published in
BMC Cancer, December 2022
DOI 10.1186/s12885-022-10454-1
Pubmed ID
Authors

Wei-Xiang Qi, Lu Cao, Siyue Zheng, Cheng Xu, Rong Cai, Haoping Xu, Gang Cai, Jiayi Chen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 17%
Student > Ph. D. Student 1 17%
Unknown 4 67%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Medicine and Dentistry 1 17%
Unknown 4 67%